Innovation : techno-push or market-driven ?

Download the report

Christophe BUREAU

Global director, Strategic Innovation, Becton Dickinson Pharmaceutical Systems, Founder, Alchimer and AlchiMedics

Seminar Management of Innovation | Wednesday May 16, 2012 - 8h45 - 10h45

Having worked for ten years in the research department of the CEA’s material sciences, Christophe Bureau created two start-ups based on the technology of electro-grafting in the microelectronic and the biomedical sectors. He raised eight million Euros after three capital pools between 2001 and 2008. AlchiMedics’ technology was used on humans at the end of 2007 and approved in 2010 in China, where the first product was launched in January 2011. Having succeeded in making a profit from a technological innovation, Christophe Bureau is now developing at Becton Dickinson an approach in which innovation is guided by market forces, irrespective of whether there is a real client in view or not, as opposed to an approach driven by technology (‘techno-push’). He is calling for conditions regarding spin-offs in France to change, as currently only techno-push based approaches (which are risky and whose profitability is hard to measure) benefit from the attention and support of institutions and financial backers.

The entire article was written by:


This session was published in issue n°100 of the Journal de l'École de Paris du management, entitled Des mondes s'ouvrent.

Google Analytics cookies
This site uses cookies from Google Analytics, these cookies help us to identify the content that interests you the most and to identify certain malfunctions. Your navigational data on this site is sent to Google Inc.